Viewing Study NCT01048892


Ignite Creation Date: 2025-12-24 @ 3:30 PM
Ignite Modification Date: 2025-12-28 @ 10:54 AM
Study NCT ID: NCT01048892
Status: COMPLETED
Last Update Posted: 2014-01-30
First Post: 2010-01-13
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Seneca Valley Virus-001 and Cyclophosphamide in Treating Young Patients With Relapsed or Refractory Neuroblastoma, Rhabdomyosarcoma, or Rare Tumors With Neuroendocrine Features
Sponsor: Children's Oncology Group
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module